An executive at Tarsus Pharmaceuticals sold 12,274 shares for approximately $839,000 at a weighted average price of $68.36 per share across three days ending March 19, 2026. The disclosure is a routine insider sale and provides limited new information on company fundamentals or strategy.
An executive at Tarsus Pharmaceuticals sold 12,274 shares for approximately $839,000 at a weighted average price of $68.36 per share across three days ending March 19, 2026. The disclosure is a routine insider sale and provides limited new information on company fundamentals or strategy.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
